Article Details
Retrieved on: 2024-04-03 14:21:25
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Alto Neuroscience, Inc. announced the initiation of its Phase 2 double-blind, single- and multiple-dose study to determine the pharmacodynamic ...
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here